Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly

Chi-Chang Huang

Status: Completed

Conditions: Elderly; Depression; Anxiety; Muscle Loss

Treatments: Dietary Supplement: Probiotics; Dietary Supplement: Placebo; Dietary Supplement: heat-treated of Lactobacillus paracasei HT-PS23

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT06062472

23-006-A2

Details and patient eligibility

About

This study refers to the supplementation of PS23 in human experiments to help the elderly maintain muscle mass, delay muscle loss, promote physical activity, and delay the occurrence of disability and debilitation in elderly people.

Full description

Taiwan has become an aging society in recent years. There are important issues to attenuate aging and activate the potential capacity of elderly population. The physical function of middle-aged and older people will degenerate with age and produce age-related diseases. Common symptoms are organ function deterioration, and old age disability caused by malnutrition and muscle loss is also a common care problem. Therefore, how to prevent the complications of muscle loss is one of the important ten years of geriatric research. Although past research has been confirmed, it can improve the debilitating condition of the elderly through nutrition counseling and exercise intervention. However, there is not much in-depth discussion on how probiotics can improve muscle loss and delay symptoms in elderly people. Therefore, this study refers to the supplementation of PS23 in human experiments to help the elderly maintain muscle mass, delay muscle loss, promote physical activity, and delay the occurrence of disability and debilitation in elderly people. One hundred and twenty elderly people will be recruited and then divided into three groups with 40 people in each group: (A) placebo group, (B) PS23 probiotic group, (C) PS23-HT prebiotic group, supplemented for 12 weeks. The diet record, functional test and muscle mass will be carried out every six weeks after the start, to understand whether PS23 is effective in improving muscle loss and weakness in elderly people.

Enrollment: 119 patients

Sex: All

Ages: 65 to 85 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• age between 65 and 85 years old

Exclusion criteria

• Have taken antibiotics within one month or are receiving antibiotic treatment
• Have used probiotic products in powder, capsule or tablet form within two weeks (except for yogurt, yogurt, Yakut and other related foods)
• People allergic to lactic acid bacteria products
• Patients diagnosed with stroke or hypertension (systolic blood pressure greater than 139, diastolic blood pressure greater than 89)
• Exclusion of limbs and hips that have been replaced with artificial joints
• Persons with incapacity/insufficient decision-making ability
• Who has been determines that it is not suitable to participate in the research.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

119 participants in 3 patient groups, including a placebo group

Probiotics

Experimental group

Description:

Probiotic capsules contain 10 billion CFU (colony forming units) of Lactobacillus paracasei, 2 caps daily use

Treatment:

Dietary Supplement: Probiotics

Heat-Treated Probiotics

Experimental group

Description:

heat-treated probiotic capsule contain 10 billion of Lactobacillus paracasei, 2 caps daily use

Treatment:

Dietary Supplement: heat-treated of Lactobacillus paracasei HT-PS23

Placebo

Placebo Comparator group

Description:

The placebo capsule contains microcrystalline cellulose, 2 caps daily use

Treatment:

Dietary Supplement: Placebo